Heart Failure Trial Patients Live Longer, But Don't Avoid Hospitalization

Patients enrolled in heart failure clinical trials showed significantly lower death rates compared to non-participants, yet experienced no reduction in hospital admissions for their condition. The finding raises questions about whether trial participation's survival benefit stems from better overall care rather than disease-specific interventions—with implications for how healthcare systems evaluate trial participation and allocate resources.

Originaltitel: Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry